Literature DB >> 2238187

[Pain and dysesthesias in the mastectomy scar].

J Skov1, K Krøner, B Krebs, H M Hvid, H S Jørgensen.   

Abstract

With the object of investigating the occurrence of pain and dysaesthesiae in the scar following mastectomy, 120 were interviewed by a standard questionnaire in a prospective study. These women had commenced postoperative control or treatment in the Department of Oncology in the University Hospital of Aarhus consecutively during a one-year period. One hundred and ten of these women were interviewed again one year later. In 92% of the patients with scar pain and dysaesthesiae, these appeared within the first three months postoperatively. At the first interview, 42 patients (35%) had scar pain and 15 of these (13%) experienced constant scar pain. One year later, 25 patients (23%) still had scar pain and 13 patients (12%) had experienced persistent scar pain throughout the entire year. Two of the patients (8%) with scar pain had constant pain while, at the second interview, 14 patients (56%) reported that the scar pain lasted for seconds. Twenty-seven patients (23%) had dysaesthesiae at the first interview while 29 patients experienced these continually one year after operation. Both the intensity and the duration of the scar pain diminished with the elapse of time. This held also true where dysaesthesiae were concerned but was not so marked.

Entities:  

Mesh:

Year:  1990        PMID: 2238187

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  2 in total

1.  Pain and other symptoms during the first year after radical and conservative surgery for breast cancer.

Authors:  T Tasmuth; K von Smitten; E Kalso
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

2.  Study protocol for a double blind, randomised, placebo-controlled trial of continuous subpectoral local anaesthetic infusion for pain and shoulder function following mastectomy: SUB-pectoral Local anaesthetic Infusion following MastEctomy (SUBLIME) study.

Authors:  R Langford; I Brown; J Vickery; K Mitchell; C Pritchard; S Creanor
Journal:  BMJ Open       Date:  2014-09-30       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.